Welcome to our dedicated page for MARSH & MCLENNAN COMPANIES SEC filings (Ticker: MRSH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on MARSH & MCLENNAN COMPANIES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into MARSH & MCLENNAN COMPANIES's regulatory disclosures and financial reporting.
MARSH & MCLENNAN COMPANIES, INC. director Deborah C. Hopkins reported an administrative Form 4 update related to her director stock compensation. On 2026-05-15, 111.82 restricted stock units were credited to her account at a reference price of $160.60 per unit through dividend equivalents.
These restricted stock units convert into Marsh & McLennan common stock on a 1-for-1 basis. Following this transaction, Hopkins directly holds a total of 20,064.74 restricted stock units under the directors stock compensation plan.
MARSH & MCLENNAN COMPANIES, INC. director Tamara Ingram reported a routine compensation-related adjustment to her equity holdings. She received 43.11 restricted stock units under the Directors Stock Compensation Plan, credited as dividend equivalents and tied to the company’s common stock on a 1-for-1 basis.
Following this transaction, Ingram holds a total of 7,736.53 restricted stock units directly. The filing does not reflect any open-market purchase or sale of Marsh & McLennan common shares, but rather an administrative update to her stock-based compensation balance.
Marsh & McLennan Companies director Lloyd M. Yates reported routine stock-based compensation activity involving restricted stock units that convert into common stock on a 1-for-1 basis. He received a grant of 225.720 restricted stock units in connection with director fees under the Directors Stock Compensation Plan.
In a separate restructuring-type entry, 60.270 restricted stock units were acquired through dividend equivalents credited to his account. Following these transactions, Yates directly holds about 11,041.170 restricted stock units, reflecting ongoing equity-based compensation rather than open-market trading.
Lute Jane H reported acquisition or exercise transactions in this Form 4 filing.
Marsh & McLennan Companies director Jane H. Lute reported routine equity compensation activity. She received 169.29 restricted stock units under the Directors Stock Compensation Plan at a reference price of $160.60 per unit. An additional 41.2 units were credited as dividend equivalents, all convertible into common stock on a 1-for-1 basis.
Marsh & McLennan director Jan Siegmund reported an internal equity adjustment involving 5.29 restricted stock units credited as dividend equivalents under the Directors Stock Compensation Plan. These units convert to common stock on a 1‑for‑1 basis, increasing his restricted stock unit holdings to 948.42.
MILLS STEVEN A reported acquisition or exercise transactions in this Form 4 filing.
MARSH & MCLENNAN COMPANIES, INC. director Steven A. Mills received an award of 264 shares of common stock at $160.60 per share as part of his director fees under the company’s Directors Stock Compensation Plan. Following this grant, he holds 4,408.75 shares directly and 47,553 shares indirectly through a trust.
MARSH & MCLENNAN COMPANIES director Anthony Anderson reported an internal adjustment involving 87.67 restricted stock units under the Directors Stock Compensation Plan. These units were credited as dividend equivalents and each converts into one share of common stock. Following this routine plan transaction, Anderson holds 15,732.33 units directly.
Marsh & McLennan Companies reported that Dean Michael Klisura, President & CEO of Guy Carpenter, received a grant of 14,907 restricted stock units. Each unit converts into one share of Marsh & McLennan common stock on a 1-for-1 basis.
The restricted stock units vest in three equal annual installments on May 15, 2027, May 15, 2028 and May 15, 2029. Following this award, Klisura is reported as directly holding 14,907 restricted stock units tied to common stock.
Marsh & McLennan Companies Chief Marketing Officer John Jude Jones received a grant of 5,963 restricted stock units as equity compensation. Each unit converts into one share of common stock. These RSUs vest in three equal annual installments on May 15, 2027, 2028 and 2029, leaving him with 5,963 units reported after this grant.
Beswick Paul reported acquisition or exercise transactions in this Form 4 filing.
Marsh & McLennan Companies reported that SVP and Chief Information Officer Paul Beswick received a grant of 14,907 restricted stock units. These RSUs represent future rights to receive an equal number of Marsh & McLennan common shares on a 1-for-1 basis.
The restricted stock units vest in three equal annual installments on May 15, 2027, May 15, 2028, and May 15, 2029, encouraging longer-term alignment between the executive and shareholders. All 14,907 RSUs are reported as directly owned following this grant.